Skip to main content
Top
Published in: BMC Women's Health 1/2009

Open Access 01-12-2009 | Research article

Tolerability of breast ductal lavage in women from families at high genetic risk of breast cancer

Authors: Jennifer T Loud, Ellen Burke Beckjord, Kathryn Nichols, June Peters, Ruthann Giusti, Mark H Greene

Published in: BMC Women's Health | Issue 1/2009

Login to get access

Abstract

Background

Ductal lavage (DL) has been proposed as a minimally-invasive, well-tolerated tool for obtaining breast epithelial cells for cytological evaluation of breast cancer risk. We report DL tolerability in BRCA1/2 mutation-positive and -negative women from an IRB-approved research study.

Methods

165 BRCA1/2 mutation-positive, 26 mutation-negative and 3 mutation unknown women underwent mammography, breast MRI and DL. Psychological well-being and perceptions of pain were obtained before and after DL, and compared with pain experienced during other screening procedures.

Results

The average anticipatedand experienceddiscomfort rating for DL, 47 and 48 (0–100), were significantly higher (p < 0.01) than the anticipatedand experienceddiscomfort of mammogram (38 and 34), MRI (36 and 25) or nipple aspiration (42 and 27). Women with greater pre-existing emotional distress experienced more DL-related discomfort than they anticipated. Women reporting DL-related pain as worse than expected were nearly three times more likely to refuse subsequent DL than those reporting it as the same or better than expected. Twenty-five percent of participants refused repeat DL at first annual follow-up.

Conclusion

DL was anticipated to be and experienced as more uncomfortable than other procedures used in breast cancer screening. Higher underlying psychological distress was associated with decreased DL tolerability.
Appendix
Available only for authorised users
Literature
1.
go back to reference Dooley WC, Ljung BM, Veronesi U, Cazzaniga M, Elledge RM, O'Shaughnessy JA, Kuerer HM, Hung DT, Khan SA, Phillips RF, Ganz PA, Euhus DM, Esserman LJ, Haffty BG, King BL, Kelley MC, Anderson MM, Schmit PJ, Clark RR, Kass FC, Anderson BO, Troyan SL, Arias RD, Quiring JN, Love SM, Page DL, King EB: Ductal lavage for detection of cellular atypia in women at high risk of breast cancer. J Natl Cancer Inst. 2001, 93 (21): 1624-1632.CrossRefPubMed Dooley WC, Ljung BM, Veronesi U, Cazzaniga M, Elledge RM, O'Shaughnessy JA, Kuerer HM, Hung DT, Khan SA, Phillips RF, Ganz PA, Euhus DM, Esserman LJ, Haffty BG, King BL, Kelley MC, Anderson MM, Schmit PJ, Clark RR, Kass FC, Anderson BO, Troyan SL, Arias RD, Quiring JN, Love SM, Page DL, King EB: Ductal lavage for detection of cellular atypia in women at high risk of breast cancer. J Natl Cancer Inst. 2001, 93 (21): 1624-1632.CrossRefPubMed
2.
go back to reference Buehring GC, Letscher A, McGirr KM, Khandhar S, Che LH, Nguyen CT, Hackett AJ: Presence of epithelial cells in nipple aspirate fluid is associated with subsequent breast cancer: a 25-year prospective study. Breast Cancer Res Treat. 2006, 29 (1): 63-70. 10.1007/s10549-005-9132-5.CrossRef Buehring GC, Letscher A, McGirr KM, Khandhar S, Che LH, Nguyen CT, Hackett AJ: Presence of epithelial cells in nipple aspirate fluid is associated with subsequent breast cancer: a 25-year prospective study. Breast Cancer Res Treat. 2006, 29 (1): 63-70. 10.1007/s10549-005-9132-5.CrossRef
3.
go back to reference Fabian CF, Kimler BF, Zelles CM, Klemp JR, Kamel S, Zeiger S, Mayo MS: Short-term breast cancer prediction by random periareolar fine-needle aspiration cytology and the Gail risk model. J Natl Cancer Inst. 2000, 92 (15): 1217-1227. 10.1093/jnci/92.15.1217.CrossRefPubMed Fabian CF, Kimler BF, Zelles CM, Klemp JR, Kamel S, Zeiger S, Mayo MS: Short-term breast cancer prediction by random periareolar fine-needle aspiration cytology and the Gail risk model. J Natl Cancer Inst. 2000, 92 (15): 1217-1227. 10.1093/jnci/92.15.1217.CrossRefPubMed
4.
go back to reference Wrensch MR, Petrakis NL, King EB, Miike R, Mason L, Chew KL, Lee MM, Ernster VL, Hilton JF, Schwitzer R, Goodsond WH, Hunt TK: Breast cancer incidence in women with abnormal cytology in nipple aspirates of breast fluid. Am J Epidemiol. 1992, 135 (2): 130-41.PubMed Wrensch MR, Petrakis NL, King EB, Miike R, Mason L, Chew KL, Lee MM, Ernster VL, Hilton JF, Schwitzer R, Goodsond WH, Hunt TK: Breast cancer incidence in women with abnormal cytology in nipple aspirates of breast fluid. Am J Epidemiol. 1992, 135 (2): 130-41.PubMed
5.
go back to reference Baltzell KA, Moghadassi M, Rice T, Sison JD, Wrensch MA: Epithelial cells in nipple aspirate fluid and subsequent breast cancer risk: A historic Prospective study. BMC Cancer. 2008, 8: 75-10.1186/1471-2407-8-75.CrossRefPubMedPubMedCentral Baltzell KA, Moghadassi M, Rice T, Sison JD, Wrensch MA: Epithelial cells in nipple aspirate fluid and subsequent breast cancer risk: A historic Prospective study. BMC Cancer. 2008, 8: 75-10.1186/1471-2407-8-75.CrossRefPubMedPubMedCentral
6.
go back to reference Fabian CJ: Is there a future for ductal lavage?. Clin Cancer Res. 2007, 13: 4655-56. 10.1158/1078-0432.CCR-07-1056.CrossRefPubMed Fabian CJ: Is there a future for ductal lavage?. Clin Cancer Res. 2007, 13: 4655-56. 10.1158/1078-0432.CCR-07-1056.CrossRefPubMed
7.
go back to reference Arun B, Valero V, Logan C, Broglio K, Rivera E, Brewster A, Yin G, Green M, Kuerer H, Gogn Y, Browne D, Hortobagyi GN, Sneige N: Comparison of ductal lavage and random periareolar fine needle aspiration as tissue acquisition methods in early breast cancer prevention trials. Clin Cancer Res. 2007, 13 (16): 4943-4948. 10.1158/1078-0432.CCR-06-2732.CrossRefPubMed Arun B, Valero V, Logan C, Broglio K, Rivera E, Brewster A, Yin G, Green M, Kuerer H, Gogn Y, Browne D, Hortobagyi GN, Sneige N: Comparison of ductal lavage and random periareolar fine needle aspiration as tissue acquisition methods in early breast cancer prevention trials. Clin Cancer Res. 2007, 13 (16): 4943-4948. 10.1158/1078-0432.CCR-06-2732.CrossRefPubMed
8.
go back to reference Carruthers DC, Chapleskie LA, Flynn MB, Frazier TG: The use of ductal lavage as a screening tool in women at high risk for developing breast carcinoma. Am J Surg. 2007, 194: 463-466. 10.1016/j.amjsurg.2007.06.020.CrossRefPubMed Carruthers DC, Chapleskie LA, Flynn MB, Frazier TG: The use of ductal lavage as a screening tool in women at high risk for developing breast carcinoma. Am J Surg. 2007, 194: 463-466. 10.1016/j.amjsurg.2007.06.020.CrossRefPubMed
9.
go back to reference Johnson-Maddux A, Ashfaq R, Cler L, Cler L, Naftalis E, Leitch AM, Hoover S, Euhus DM: Reproducibility of cytologic atypia in repeat nipple duct lavage. Cancer. 2005, 103: 1129-1136. 10.1002/cncr.20884.CrossRefPubMed Johnson-Maddux A, Ashfaq R, Cler L, Cler L, Naftalis E, Leitch AM, Hoover S, Euhus DM: Reproducibility of cytologic atypia in repeat nipple duct lavage. Cancer. 2005, 103: 1129-1136. 10.1002/cncr.20884.CrossRefPubMed
10.
go back to reference Higgins SA, Matloff ET, Rimm DL, Dziura J, Haffty BG, King BL: Patterns of reduced nipple aspirate fluid production and ductal lavagle cellularity in women at high risk for breast cancer. Breast Cancer Res and Treat. 2005, 7: 1017-1022. 10.1186/bcr1335.CrossRef Higgins SA, Matloff ET, Rimm DL, Dziura J, Haffty BG, King BL: Patterns of reduced nipple aspirate fluid production and ductal lavagle cellularity in women at high risk for breast cancer. Breast Cancer Res and Treat. 2005, 7: 1017-1022. 10.1186/bcr1335.CrossRef
11.
go back to reference Patil DB, Lankes HA, Nayar R, Nayar R, Masood S, Bryk M, Hou N, Rademaker , Khan SA: Reproducibility of ductal lavage cytology and cellularity over a six month interval in high risk women. Breast Cancer Res and Treat. 2008, 112 (2): 327-333. 10.1007/s10549-007-9861-8.CrossRef Patil DB, Lankes HA, Nayar R, Nayar R, Masood S, Bryk M, Hou N, Rademaker , Khan SA: Reproducibility of ductal lavage cytology and cellularity over a six month interval in high risk women. Breast Cancer Res and Treat. 2008, 112 (2): 327-333. 10.1007/s10549-007-9861-8.CrossRef
12.
go back to reference Sharma P, Klemp JR, Simensen M, Welsko CM, Zalles CM, Kimler BF, Fabian CJ: Failure of high risk women to produce nipple aspirate does not exclude detection of cytologic atypia in random periareolar needle aspiration specimens. Breast Cancer Res and Treat. 2004, 87: 59-64. 10.1023/B:BREA.0000041582.11586.d3.CrossRef Sharma P, Klemp JR, Simensen M, Welsko CM, Zalles CM, Kimler BF, Fabian CJ: Failure of high risk women to produce nipple aspirate does not exclude detection of cytologic atypia in random periareolar needle aspiration specimens. Breast Cancer Res and Treat. 2004, 87: 59-64. 10.1023/B:BREA.0000041582.11586.d3.CrossRef
13.
go back to reference Visvanathan K, Santor D, Ali SZ, Brewster A, Arnold A, Armstrong DK, Davidson NE, Helzlsouer KJ: The reliability of nipple aspirate and ductal lavage in women at increased risk for breast cancer – a potential tool for breast cancer risk assessment and biomarker evaluation. Cancer Epidemiol Biomarkers Prev. 2007, 16 (5): 950-955. 10.1158/1055-9965.EPI-06-0974.CrossRefPubMed Visvanathan K, Santor D, Ali SZ, Brewster A, Arnold A, Armstrong DK, Davidson NE, Helzlsouer KJ: The reliability of nipple aspirate and ductal lavage in women at increased risk for breast cancer – a potential tool for breast cancer risk assessment and biomarker evaluation. Cancer Epidemiol Biomarkers Prev. 2007, 16 (5): 950-955. 10.1158/1055-9965.EPI-06-0974.CrossRefPubMed
14.
go back to reference Zalles CM, Kimler BF, Simonsen M, Clark JL, Metheny T, Fabian CJ: Comparison of cytomorphology in specimens obtained by random periareolar fine needle aspiration and ductal lavage from women at high risk for development of breast cancer. Breast Cancer Res Treat. 2006, 97: 191-7. 10.1007/s10549-005-9111-x.CrossRefPubMed Zalles CM, Kimler BF, Simonsen M, Clark JL, Metheny T, Fabian CJ: Comparison of cytomorphology in specimens obtained by random periareolar fine needle aspiration and ductal lavage from women at high risk for development of breast cancer. Breast Cancer Res Treat. 2006, 97: 191-7. 10.1007/s10549-005-9111-x.CrossRefPubMed
15.
go back to reference Abati A, Greene MH, Filie AC, Loud J, Prindiville S, Danforth D, Guisti RM: Quantification of the cellular components of breast ductal lavage samples. Diagn Ctyopathol. 2006, 34: 78-81. 10.1002/dc.20371.CrossRef Abati A, Greene MH, Filie AC, Loud J, Prindiville S, Danforth D, Guisti RM: Quantification of the cellular components of breast ductal lavage samples. Diagn Ctyopathol. 2006, 34: 78-81. 10.1002/dc.20371.CrossRef
16.
go back to reference Danforth DN, Abati A, Filie A, Prindiville SA, Palmieri D, Simon R, Ried T, Steeg PS: Combined breast ductal lavage and ductal endoscopy for evaluation of the high-risk breast: a feasibility study. J Surg Onc. 2006, 94: 555-64. 10.1002/jso.20650.CrossRef Danforth DN, Abati A, Filie A, Prindiville SA, Palmieri D, Simon R, Ried T, Steeg PS: Combined breast ductal lavage and ductal endoscopy for evaluation of the high-risk breast: a feasibility study. J Surg Onc. 2006, 94: 555-64. 10.1002/jso.20650.CrossRef
17.
go back to reference Loud J, Thiebaut ACM, Abati AD, Filie AC, Nichols K, Danforth D, Guisti R, Prindiville SA, Greene MH: Ductal Lavage in Women from BRCA1/2 Families: Is there a future for ductal lavage in women at increased genetic risk of breast cancer?. Cancer Epidemiol Biomarkers Prev. 2009, 18 (4): 1243-51. 10.1158/1055-9965.EPI-08-0795.CrossRefPubMedPubMedCentral Loud J, Thiebaut ACM, Abati AD, Filie AC, Nichols K, Danforth D, Guisti R, Prindiville SA, Greene MH: Ductal Lavage in Women from BRCA1/2 Families: Is there a future for ductal lavage in women at increased genetic risk of breast cancer?. Cancer Epidemiol Biomarkers Prev. 2009, 18 (4): 1243-51. 10.1158/1055-9965.EPI-08-0795.CrossRefPubMedPubMedCentral
18.
go back to reference Mitchell G, Antill YC, Murray W, Kirk J, Salisbury E, Lindeman GJ, Di Iulio J, Milner AD, Devereaux L, Phillips KA: Nipple aspiration and ductal lavage in women with a germline BRCA1 or BRCA2 mutation. Breast Cancer Res. 2005, 7 (6): 1122-31. 10.1186/bcr1348.CrossRef Mitchell G, Antill YC, Murray W, Kirk J, Salisbury E, Lindeman GJ, Di Iulio J, Milner AD, Devereaux L, Phillips KA: Nipple aspiration and ductal lavage in women with a germline BRCA1 or BRCA2 mutation. Breast Cancer Res. 2005, 7 (6): 1122-31. 10.1186/bcr1348.CrossRef
19.
go back to reference Kurian AW, Hartman AF, Mills MA, Jaffee M, Sigal BM, Chun NM, Kingham KE, Collins LC, Nowels KW, Plevritis SK, Garber JE, Ford JM, Hartman AR: Opinions of women with high inherited breast cancer risk about prophylactic mastectomy: an initial evaluation from a screening trial including magnetic resonance imaging and ductal lavage. Health Expect. 2006, 8: 221-233. 10.1111/j.1369-7625.2005.00333.x.CrossRef Kurian AW, Hartman AF, Mills MA, Jaffee M, Sigal BM, Chun NM, Kingham KE, Collins LC, Nowels KW, Plevritis SK, Garber JE, Ford JM, Hartman AR: Opinions of women with high inherited breast cancer risk about prophylactic mastectomy: an initial evaluation from a screening trial including magnetic resonance imaging and ductal lavage. Health Expect. 2006, 8: 221-233. 10.1111/j.1369-7625.2005.00333.x.CrossRef
20.
go back to reference Gail MH, Brinton LA, Byar DP, Corle DK, Green SB, Schairer C, Mulvihill JJ: Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst. 1989, 81: 1879-86. 10.1093/jnci/81.24.1879.CrossRefPubMed Gail MH, Brinton LA, Byar DP, Corle DK, Green SB, Schairer C, Mulvihill JJ: Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst. 1989, 81: 1879-86. 10.1093/jnci/81.24.1879.CrossRefPubMed
21.
go back to reference Euhus DM, Bu D, Ashfaq R, Xie XJ, Bian A, Leitch AM, Lewis CM: Atypia and DNA methylation in nipple duct lavage in relation to predicted breast cancer risk. Cancer Epidemiol Biomarkers Prev. 2007, 16: 1812-21. 10.1158/1055-9965.EPI-06-1034.CrossRefPubMed Euhus DM, Bu D, Ashfaq R, Xie XJ, Bian A, Leitch AM, Lewis CM: Atypia and DNA methylation in nipple duct lavage in relation to predicted breast cancer risk. Cancer Epidemiol Biomarkers Prev. 2007, 16: 1812-21. 10.1158/1055-9965.EPI-06-1034.CrossRefPubMed
22.
go back to reference Bruyninckx E, Mortelmans D, Van Goethem M, Van Hove E: Risk factors of pain in mammographic screening. Soc Sci Med. 1999, 49: 933-941. 10.1016/S0277-9536(99)00181-1.CrossRefPubMed Bruyninckx E, Mortelmans D, Van Goethem M, Van Hove E: Risk factors of pain in mammographic screening. Soc Sci Med. 1999, 49: 933-941. 10.1016/S0277-9536(99)00181-1.CrossRefPubMed
23.
go back to reference Keemers-Gels ME, Groenendijk RP, Heuvel van den JH, Boetes C, Peer PG, Wobbes TH: Pain experienced by women attending breast cancer screening. Breast Cancer Res Treat. 2000, 60: 235-240. 10.1023/A:1006457520996.CrossRefPubMed Keemers-Gels ME, Groenendijk RP, Heuvel van den JH, Boetes C, Peer PG, Wobbes TH: Pain experienced by women attending breast cancer screening. Breast Cancer Res Treat. 2000, 60: 235-240. 10.1023/A:1006457520996.CrossRefPubMed
24.
go back to reference Papas M, Klassen AC: Pain and Discomfort Associated with Mammography Among Urban Low-Income African-American Women. J Community Health. 2005, 30 (4): 253-267. 10.1007/s10900-005-3704-5.CrossRefPubMed Papas M, Klassen AC: Pain and Discomfort Associated with Mammography Among Urban Low-Income African-American Women. J Community Health. 2005, 30 (4): 253-267. 10.1007/s10900-005-3704-5.CrossRefPubMed
25.
go back to reference Carney PA, Harwood BG, Weiss JE, Eliassen MS, Goodrich ME: Factors associated with interval adherence to mammography screening in a population-based sample of New Hampshire women. Cancer. 2002, 95 (2): 219-27. 10.1002/cncr.10681.CrossRefPubMed Carney PA, Harwood BG, Weiss JE, Eliassen MS, Goodrich ME: Factors associated with interval adherence to mammography screening in a population-based sample of New Hampshire women. Cancer. 2002, 95 (2): 219-27. 10.1002/cncr.10681.CrossRefPubMed
26.
go back to reference Antoniou A, Pharoah PD, Narod S, Risch HA, Eyfjord JE, Hopper JL, Loman N, Olsson H, Johannsson O, Borg A, Pasini B, Radice P, Manoukian S, Eccles DM, Tang N, Olah E, Anton-Culver H, Warner E, Lubinski J, Gronwald J, Gorski B, Tulinius H, Thorlacius S, Eerola H, Nevanlinna H, Syrjäkoski K, Kallioniemi OP, Thompson D, Evans C, Peto J, Lalloo F, Evans DG, Easton DF: Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet. 2003, 72: 1117-113. 10.1086/375033.CrossRefPubMedPubMedCentral Antoniou A, Pharoah PD, Narod S, Risch HA, Eyfjord JE, Hopper JL, Loman N, Olsson H, Johannsson O, Borg A, Pasini B, Radice P, Manoukian S, Eccles DM, Tang N, Olah E, Anton-Culver H, Warner E, Lubinski J, Gronwald J, Gorski B, Tulinius H, Thorlacius S, Eerola H, Nevanlinna H, Syrjäkoski K, Kallioniemi OP, Thompson D, Evans C, Peto J, Lalloo F, Evans DG, Easton DF: Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet. 2003, 72: 1117-113. 10.1086/375033.CrossRefPubMedPubMedCentral
27.
go back to reference King MC, Marks JH, Mandell JB, New York Breast Cancer Study Group: Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science. 2003, 302: 643-646. 10.1126/science.1088759.CrossRefPubMed King MC, Marks JH, Mandell JB, New York Breast Cancer Study Group: Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science. 2003, 302: 643-646. 10.1126/science.1088759.CrossRefPubMed
28.
go back to reference Nathanson DL, Wooster R, Weber BL: Breast cancer genetics: what we know and what we need. Nat Med. 2001, 7 (5): 552-6. 10.1038/87876.CrossRefPubMed Nathanson DL, Wooster R, Weber BL: Breast cancer genetics: what we know and what we need. Nat Med. 2001, 7 (5): 552-6. 10.1038/87876.CrossRefPubMed
29.
go back to reference Peto J: Breast cancer susceptibility-A new look at an old model. Cancer Cell. 2002, 1 (5): 411-2. 10.1016/S1535-6108(02)00079-X.CrossRefPubMed Peto J: Breast cancer susceptibility-A new look at an old model. Cancer Cell. 2002, 1 (5): 411-2. 10.1016/S1535-6108(02)00079-X.CrossRefPubMed
30.
go back to reference Narod SA, Brunet JS, Ghadirian P, Robson M, Heimdal K, Neuhausen SL, Stoppa-Lyonnet D, Lerman C, Pasini B, de los Rios P, Weber B, Lynch H: Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study. Lancet. 2000, 356: 1876-81. 10.1016/S0140-6736(00)03258-X.CrossRefPubMed Narod SA, Brunet JS, Ghadirian P, Robson M, Heimdal K, Neuhausen SL, Stoppa-Lyonnet D, Lerman C, Pasini B, de los Rios P, Weber B, Lynch H: Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study. Lancet. 2000, 356: 1876-81. 10.1016/S0140-6736(00)03258-X.CrossRefPubMed
31.
go back to reference King MC, Wieand S, Hale K, Lee M, Walsh T, Owens K, Tait J, Ford L, Dunn BK, Costantino J, Wickerham L, Wolmark N, Fisher B: Tamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2: National Surgical Adjuvant Breast and Bowel Project NSABP-P1) Breast Cancer Prevention Trial. JAMA. 2001, 286: 2251-6. 10.1001/jama.286.18.2251.CrossRefPubMed King MC, Wieand S, Hale K, Lee M, Walsh T, Owens K, Tait J, Ford L, Dunn BK, Costantino J, Wickerham L, Wolmark N, Fisher B: Tamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2: National Surgical Adjuvant Breast and Bowel Project NSABP-P1) Breast Cancer Prevention Trial. JAMA. 2001, 286: 2251-6. 10.1001/jama.286.18.2251.CrossRefPubMed
32.
go back to reference Metcalf K, Lynch HT, Ghadirian P, Tung N, Olivotto I, Warner E, Olopade OI, Eisen A, Weber B, McLennan J, Sun P, Foulkes WD, Narod SA: Contralateral breast cancer in BRCA1 and BRCA2 mutations carriers. J Clin Oncol. 2004, 22: 2328-35. 10.1200/JCO.2004.04.033.CrossRef Metcalf K, Lynch HT, Ghadirian P, Tung N, Olivotto I, Warner E, Olopade OI, Eisen A, Weber B, McLennan J, Sun P, Foulkes WD, Narod SA: Contralateral breast cancer in BRCA1 and BRCA2 mutations carriers. J Clin Oncol. 2004, 22: 2328-35. 10.1200/JCO.2004.04.033.CrossRef
33.
go back to reference Bouchard L, Blancquaert I, Eisinger F, Foulkes WD, Evans G, Sobol H, Julian-Reynier C: Prevention and genetic testing for breast cancer: variations in medical decisions. Soc Sci Med. 2004, 58: 1085-1096. 10.1016/S0277-9536(03)00263-6.CrossRefPubMed Bouchard L, Blancquaert I, Eisinger F, Foulkes WD, Evans G, Sobol H, Julian-Reynier C: Prevention and genetic testing for breast cancer: variations in medical decisions. Soc Sci Med. 2004, 58: 1085-1096. 10.1016/S0277-9536(03)00263-6.CrossRefPubMed
34.
go back to reference Hartman AF, Daniel BL, Kurian AW, Mills MA, Nowels KW, Dirbas FM, Kingham KE, Chun NM, Herfkens RJ, Ford JM, Plevritis SK: Breast magnetic resonance image screening and ductal lavage in women at high genetic risk for breast carcinoma. Cancer. 2004, 100: 479-489. 10.1002/cncr.11926.CrossRefPubMed Hartman AF, Daniel BL, Kurian AW, Mills MA, Nowels KW, Dirbas FM, Kingham KE, Chun NM, Herfkens RJ, Ford JM, Plevritis SK: Breast magnetic resonance image screening and ductal lavage in women at high genetic risk for breast carcinoma. Cancer. 2004, 100: 479-489. 10.1002/cncr.11926.CrossRefPubMed
35.
go back to reference Hartmann LC, Schaid DJ, Woods JE, Crotty TP, Myers JL, Arnold PG, Petty PM, Sellers TA, Johnson JL, McDonnell SK, Frost MH, Jenkins RB: Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer. N Engl J Med. 1999, 340: 77-84. 10.1056/NEJM199901143400201.CrossRefPubMed Hartmann LC, Schaid DJ, Woods JE, Crotty TP, Myers JL, Arnold PG, Petty PM, Sellers TA, Johnson JL, McDonnell SK, Frost MH, Jenkins RB: Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer. N Engl J Med. 1999, 340: 77-84. 10.1056/NEJM199901143400201.CrossRefPubMed
36.
go back to reference Kauff N, Satagopan JM, Robson ME, Scheuer L, Hensley M, Hudis CA, Ellis NA, Boyd J, Borgen PI, Barakat RR, Norton L, Castiel M, Nafa K, Offit K: Risk-reducing salpingo-oophorectomy in women with BRCA1 or BRCA2 mutation. N Engl J Med. 2002, 346: 1609-15. 10.1056/NEJMoa020119.CrossRefPubMed Kauff N, Satagopan JM, Robson ME, Scheuer L, Hensley M, Hudis CA, Ellis NA, Boyd J, Borgen PI, Barakat RR, Norton L, Castiel M, Nafa K, Offit K: Risk-reducing salpingo-oophorectomy in women with BRCA1 or BRCA2 mutation. N Engl J Med. 2002, 346: 1609-15. 10.1056/NEJMoa020119.CrossRefPubMed
37.
go back to reference Meijers-Heijboer H, Brekelmans CT, Menke-Pluymers M, Seynaeve C, Baalbergen A, Burger C, Crepin E, Ouweland van den AW, van Geel B, Klijn JG: Use of genetic testing and prophylactic mastectomy and oophorectomy in women with breast or ovarian cancer from families with a BRCA1 or BRCA2 mutation. J Clin Oncol. 2003, 21: 1675-81. 10.1200/JCO.2003.09.052.CrossRefPubMed Meijers-Heijboer H, Brekelmans CT, Menke-Pluymers M, Seynaeve C, Baalbergen A, Burger C, Crepin E, Ouweland van den AW, van Geel B, Klijn JG: Use of genetic testing and prophylactic mastectomy and oophorectomy in women with breast or ovarian cancer from families with a BRCA1 or BRCA2 mutation. J Clin Oncol. 2003, 21: 1675-81. 10.1200/JCO.2003.09.052.CrossRefPubMed
38.
go back to reference Domcheck SM, Weber BL: Clinical management of BRCA1 and BRCA2 mutation carriers. Oncogene. 2006, 255825-5831. Domcheck SM, Weber BL: Clinical management of BRCA1 and BRCA2 mutation carriers. Oncogene. 2006, 255825-5831.
40.
go back to reference Zabora J, Brintzehofe-Szoc K, Jacobsen P, Curbow B, Piantadosi S, Hooker C, Owens A, Derogatis L: A new psychosocial screening instrument for use with cancer patients. Psychosomatics. 2001, 41 (3): 241-6. 10.1176/appi.psy.42.3.241.CrossRef Zabora J, Brintzehofe-Szoc K, Jacobsen P, Curbow B, Piantadosi S, Hooker C, Owens A, Derogatis L: A new psychosocial screening instrument for use with cancer patients. Psychosomatics. 2001, 41 (3): 241-6. 10.1176/appi.psy.42.3.241.CrossRef
41.
go back to reference Kramer J, Velazquez I, Chen BS, Rosenberg PS, Struewing JP, Greene MH: Prophylactic oophorectomy reduces breast cancer penetrance during prospective, long-term follow-up of BRCA1 mutation carriers. J Clin Oncol. 2005, 23: 8629-8635. 10.1200/JCO.2005.02.9199.CrossRefPubMed Kramer J, Velazquez I, Chen BS, Rosenberg PS, Struewing JP, Greene MH: Prophylactic oophorectomy reduces breast cancer penetrance during prospective, long-term follow-up of BRCA1 mutation carriers. J Clin Oncol. 2005, 23: 8629-8635. 10.1200/JCO.2005.02.9199.CrossRefPubMed
42.
go back to reference Conley B, O'Shaughnessy J, Prindiville S, Lawrence J, Chow C, Jones E, Merino MJ, Kaiser-Kupfer MI, Caruso RC, Podgor M, Goldspiel B, Venzon D, Danforth D, Wu S, Noone M, Goldstein J, Cowan KH, Zujewski J: Pilot trial of the safety, tolerability, and retinoid levels of N-(4-hydroxyphenyl) retinamide in combination with tamoxifen in patients at high risk for developing invasive breast cancer. J Clin Oncol. 2000, 18 (2): 275-83.PubMed Conley B, O'Shaughnessy J, Prindiville S, Lawrence J, Chow C, Jones E, Merino MJ, Kaiser-Kupfer MI, Caruso RC, Podgor M, Goldspiel B, Venzon D, Danforth D, Wu S, Noone M, Goldstein J, Cowan KH, Zujewski J: Pilot trial of the safety, tolerability, and retinoid levels of N-(4-hydroxyphenyl) retinamide in combination with tamoxifen in patients at high risk for developing invasive breast cancer. J Clin Oncol. 2000, 18 (2): 275-83.PubMed
Metadata
Title
Tolerability of breast ductal lavage in women from families at high genetic risk of breast cancer
Authors
Jennifer T Loud
Ellen Burke Beckjord
Kathryn Nichols
June Peters
Ruthann Giusti
Mark H Greene
Publication date
01-12-2009
Publisher
BioMed Central
Published in
BMC Women's Health / Issue 1/2009
Electronic ISSN: 1472-6874
DOI
https://doi.org/10.1186/1472-6874-9-20

Other articles of this Issue 1/2009

BMC Women's Health 1/2009 Go to the issue